Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Colorado for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Colorado only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Colorado (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Tamara Miller (NPI 1982659017)

Key Findings

Field	Value
Entity Type	Individual
Organization	Tamara Miller
Address	2121 E Harmony Rd
City	Fort Collins
State	CO
ZIP	80528
Taxonomy	Specialist
NPI Enumerated	May 24, 2006

Payer Source	Total Paid
Medicare	$1.4M
Medicaid	$0

This provider’s Medicare footprint is the dominant (and effectively sole) payer presence on file: total Medicare revenue is $1.4M while there is no Medicaid billing on file. The absence of any Medicaid claims indicates this practice operates as a de facto single‑payer (Medicare) business for the available public claims data and may therefore be more exposed to Medicare reimbursement and utilization changes than peers with mixed payer mixes.

Revenue is highly concentrated: the precomputed top three Medicare codes account for 92.9% of the provider’s total Medicare revenue. Those codes — J2350 ($883.2K, 60.9%), J0585 ($442.8K, 30.5%), and 99215 ($21.9K, 1.5%) — drive almost all reported Medicare dollars, indicating a narrow set of services produce the bulk of income.

The procedure mix points to a specialty practice focused on high‑cost biologic infusions and procedural chemodenervation. J2350 (ocrelizumab) and J0585 (onabotulinumtoxina) together represent the vast majority of revenue, and the presence of procedure codes such as 64616, 64615, 64612 and the EMG add‑on 95874 supports an operational model built around injectable/infusion therapies and targeted neurotoxin procedures rather than primary care office‑only care.

Onabotulinumtoxina (J0585) is a major national volume outlier for this provider: J0585 generated $442.8K (30.5% of Medicare revenue) and the provider ranks #23 of 3636 providers nationally (99th percentile; notably above typical national volume). This indicates national‑level volume and operational scale for J0585 within the provider’s treatment mix and may reflect specialization or a high procedural throughput for onabotulinumtoxina services.

Ocrelizumab (J2350) drives the single largest share of Medicare revenue ($883.2K, 60.9%), but the provider’s competitive standing for this code is more typical within its smaller peer set: J2350 ranks #28 of 105 providers nationally (73th percentile; typical, unremarkable volume for this code). In other words, J2350 dominates this provider’s dollars without placing them at the very top of national volume for that specific drug.

Several related procedural codes are reported at volumes above typical national levels, underscoring procedural depth beyond drug administration: 64616 ranks #38 of 775 (95th percentile; notably above typical national volume), 95874 ranks #51 of 1137 (95th percentile; notably above typical national volume), and 64615 ranks #116 of 1825 (94th percentile; typical, unremarkable volume). These elevated ranks for chemodenervation and EMG add‑ons suggest consistent use of interventional neuromuscular procedures alongside infusion services.

Evaluation and management codes appear as expected adjuncts to the procedural mix: 99215 generated $21.9K (1.5%) and ranks #15383 of 145531 (89th percentile; typical, unremarkable volume), while 99214 and 99213 also appear at modest revenue shares. This pattern indicates the practice pairs higher‑acuity office visits with its procedural work rather than relying primarily on E&M revenue.

The provider’s NPI was enumerated on 2006-05-24 (~20 years ago), indicating long tenure in the Medicare program. Combined with the concentrated, specialized revenue profile, the tenure suggests an established, procedure‑focused practice that has developed a steady case mix centered on high‑cost biologic infusions and chemodenervation services.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2350	Injection, ocrelizumab, 1 mg	19,200	$50	$883.2K
J0585	Injection, onabotulinumtoxina, 1 unit	88,550	$10	$442.8K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	170	$130	$21.9K
64616	The provider administers a chemical compound to the neck muscles on one side, avoiding the laryngeal muscles. The goal of this procedure is to paralyze the muscles. Providers may treat cervical…	150	$130	$19.8K
64615	The provider bilaterally administers a chemical compound to the muscles innervated by the trigeminal, facial, cervical spinal, and accessory nerves. The goal of this procedure is to paralyze the…	140	$110	$14.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	190	$70	$13.1K
95874	In this add–on procedure, the provider uses needle electromyography guidance for a chemodenervation injection. Chemodenervation is a process of injecting a neurotoxin like ethyl alcohol or Botox®…	180	$70	$11.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	120	$90	$11.5K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	100	$100	$9.7K
64612	In this procedure, the provider injects a chemical on one side of the face to disable the facial nerve and relieve painful facial nerve disorders or abnormal involuntary movements of facial muscles.	60	$150	$9.4K

Showing 1–10 of 16

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Harmony Surgery Center, LLC	CO	Ambulatory Surgical Clinic/Center	$5.4M	$2.8M
Noco Pediatric Ot, LLC	CO	Occupational Therapist	$0	$5.7M
Tender Care Pediatric Services, Inc	CO	In Home Supportive Care Agency	$0	$5.4M
Surgery Center Of Northern Colorado	CO	Ambulatory Surgical Clinic/Center	$4.3M	$702.8K
E Plus Pet Imaging Xviii LP	CO	Radiology Clinic/Center	$2.1M	$964.4K
Charles Sisson	CO	Pain Medicine (Anesthesiology) Physician	$2.6M	$0
Matthew Asano	CO	Ophthalmology Physician	$2M	$0
Michael Thakor	CO	Rheumatology Physician	$1.8M	$0
Harmony Imaging Center LLC	CO	Diagnostic Radiology Physician	$1.1M	$417.9K
Joshua Petit	CO	Radiation Oncology Physician	$443.5K	$0

Tamara Miller — Billing Profile & Reimbursement Data

Sign up for Tamara Miller — Billing Profile & Reimbursement Data policy alerts

Tamara Miller — Billing Profile & Reimbursement Data

Sign up for Tamara Miller — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Nearby Providers

Frequently Asked Questions

References

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J2350	1	10	15,000	$50	$683.4K
J0585	2	100	7,900	$1	$73.7K
96413	79	140	130	$100	$19.7K
99214	3,047	8,160	80	$80	$11.3K
64616	2	20	60	$130	$8.7K
99215	324	3,230	40	$110	$8.1K
64615	7	50	60	$100	$8K
64612	4	10	60	$140	$7.9K
99213	1,212	7,200	70	$60	$6.6K
99205	909	1,300	20	$150	$5K